Lipid nanoparticle (LNP)-delivered FAK siRNA and CRISPER-PD-L1 enhance gene editing by reducing tumor ECM stiffness in liver cancer, therefore inhibiting in vivo tumor growth and extending survival of tumor-bearing mice [394]. The gene discussed is PTK2; the disease is neoplasm.